Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance
On January 20, the price target on Soleno Therapeutics (NASDAQ:SLNO) was increased from $110 to $120 by Ram Selvaraju from H.C. Wainwright.
Soleno Therapeutics Inc (SLNO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 2,900,000 | $134,270,000 | +13% | 1.32% |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,314,002 | $60,838,293 | +53% | 2.01% |
| 3. | Millennium Management Israel Englander | 1,236,321 | $57,241,662 | +27% | 0.02% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,200,000 | $55,560,000 | -12% | 3.7% |
| 5. | Braidwell LP Alex Karnal | 1,187,859 | $54,997,872 | -8% | 1.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 250,000 | $5,000,000.00 | 3,074,542 | 2023-09-28 | Filing | |
| $21.00 | 36,939 | $775,719.00 | 2,824,542 | 2023-09-26 | Filing | |
| $20.03 | 117,996 | $2,363,459.88 | 2,787,603 | 2023-09-26 | Filing | |
| $19.11 | 88,685 | $1,694,770.35 | 2,669,607 | 2023-09-26 | Filing | |
| $18.24 | 52,691 | $961,083.84 | 2,580,922 | 2023-09-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.76 | 3,830 | $316,970.80 | 13,206 | 2025-07-01 | Filing | |
| $84.25 | 266 | $22,410.50 | 17,036 | 2025-06-24 | Filing | |
| $70.11 | 3,782 | $265,156.02 | 27,036 | 2025-04-01 | Filing | |
| $71.55 | 5,937 | $424,797.10 | 6,500 | 2025-03-28 | Filing | |
| $66.95 | 23,475 | $1,571,716.98 | 28,143 | 2025-03-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,079,304 | $374,071,758 | 0.02% | |
| 2. | 7,178,354 | $332,302,144 | 0.15% | |
| 3. | 3,871,639 | $179,256,886 | 0% | |
| 4. | 3,322,799 | $153,845,595 | 0.03% | |
| 5. | 3,060,361 | $141,694,714 | 0% |
News See All
17 Biotechnology Stocks with More Than 50% Upside
2025 was a year characterized by both challenges and opportunities for the biotechnology sector.
10 Cheap Stocks with Huge Upside Potential
We’re only one month into 2026, and the progress of global economies has been anything but normal.
Is Soleno Therapeutics, Inc. (NASDAQ:SLNO) The Best Under $50 Stock to Buy Now?
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is among the stocks under $50 to buy now. On January 20, TheFly reported that H.C. Wainwright lifted the price target on Soleno Therapeutics, Inc.
12 Stocks Under $50 to Buy Now
These days, everyone is seeking high returns with the minimum possible investment, and in a market dominated by big names and elevated valuations, it is challenging to identify stocks that are actually...
Soleno Therapeutics Inc. (SLNO): Analysts See Major Upside
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the best cheap stocks that will skyrocket.
10 Best Cheap Stocks That Will Skyrocket
Rotation into cheap stocks is becoming increasingly popular as investors explore ways to circumvent premium valuations in equity markets.
12 Stocks that Will Bounce Back According to Wall Street Analysts
On January 5, Reuters reported that many analysts believe global investors will actively look for opportunities in undervalued areas of the financial markets in 2026.
Do You Believe in the Growth Prospects of Soleno Therapeutics (SLNO)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2025 investor letter.
Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026?
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Soleno Therapeutics, Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
